|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Mar―22 |
Association of the medication protocols and longitudinal change of COVID-19 symptoms: a hospital-based mixed-statistical methods study |
Zahra Rezaei Ghahroodi, Samaneh Eftekhari Mahabadi, Alireza Esberizi, Ramin Sami, Marjan Mansourian |
2 |
[GO] |
2023―Jan―31 |
Assessing adverse events in clinical trials during the era of the COVID-19 pandemic |
James Buchanan, Mengchun Li, Barbara Hendrickson, Parul Bhargava, Satrajit Roychoudhury |
3 |
[GO] |
2021―Sep―23 |
Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trials |
Samvel B. Gasparyan, Elaine K. Kowalewski, Folke Folkvaljon, Olof Bengtsson, Joan Buenconsejo, John Adler, Gary G. Koch |
4 |
[GO] |
2021―Aug―18 |
Estimands, Handling of Missing Data and Impact on Assumed Effect Size and Power in Pivotal COVID-19 Treatment Trials |
Sujatro Chakladar, Ran Liao, Margaret Gamalo |